Frontlight ResearchEarly access
Diabetic eye disease trials in United States
8 of 47 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleNational Eye Institute Biorepository for Retinal Diseases
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 650
- Run by
- National Eye Institute (NEI)
See details and how to joinNCT01496625 - No phaseTaking peopleHuman iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
- Where
- Birmingham
- Age
- 21 years to 98 years
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT03403699 - No phaseTaking peopleIntraoperative OCT Guidance of Intraocular Surgery II
- Where
- Durham
- Age
- 4 weeks and over
- People
- 262
- Run by
- Duke University
See details and how to joinNCT03713268 - No phaseTaking peopleLiver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- Where
- Birmingham
- Age
- 21 years to 98 years
- People
- 104
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT03403686 - No phaseTaking peoplePivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy
- Where
- Jacksonville
- Age
- 22 years and over
- People
- 800
- Run by
- Digital Diagnostics, Inc.
See details and how to joinNCT07844317 - No phaseTaking peopleBiomarker of Diabetic Retinopathy
- Where
- Carmel, Indianapolis
- Age
- 18 years and over
- People
- 192
- Run by
- Indiana University
See details and how to joinNCT05079399 - No phaseTaking peopleAssessment of AI Program 'DRISTi' as a Screening Tool
- Where
- Oxford, Raleigh
- Age
- 21 years and over
- People
- 900
- Run by
- Artelus AI
See details and how to joinNCT07222293 - No phaseTaking peopleA Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- Where
- Dallas
- Age
- 18 years and over
- People
- 30
- Run by
- Nanoscope Therapeutics Inc.
See details and how to joinNCT06805474